Medpace Stock Plunges 15.9% as Class Action Lawsuit Alleges Investor Guidance Misrepresentation
Medpace Holdings faces $MEDP class action lawsuit after stock plunges 15.9% due to book-to-bill ratio guidance miss: 1.04x actual vs. 1.15x guided.
MEDPclass action lawsuitstock decline
